Global Bio-MEMS Market Research Report

In the Global BIO-MEMS Devices Market, the usefulness of these devices is two-fold: firstly, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. For example, the introduction of accelerometers in pacemakers has revolutionized the treatment of cardiac diseases. The BioMEMS market is expected to grow rapidly, from $2.3 Billion in 2014 to $6.6 Billion by 2019, at a CAGR of around 23%, for the given period.

The report “The Global BIO-MEMS Devices Market forecast, 2014-2019” analyzes the market of devices by products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators. Bio-Chips and BIO-MEMS segments experienced a positive growth till 2013 with an increased awareness for procedures and sophisticated diagnostic techniques. Bio-Chips and BIO-MEMS markets have been witnessing the maximum growth because of increase in patient pool and revolutionary treatment for cardiology, neurology, oncology etc.

The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others.

Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

Customization Options:

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:

Product Analysis

• Usage pattern (in-depth trend analysis) of products (Segment wise)
• Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
• End-user Adoption rate analysis of the products (Segment wise and Country wise)
• Comprehensive coverage of Product approvals, Pipeline products and Product recalls

Surgeons/Physicians Forum

• Fast turn-around analysis of Surgeons response to market events and trends
• Pattern analysis of usage of BIO-MEMS by Physicians
• Surgeons opinion about products from different companies
• Surgeons qualitative inputs on epidemiology data

Epidemiology Data

• Country specific Prevalence of Heart attack and stroke
• Country specific Incidence of Heart attack and stroke
• Country specific Mortality rate of Stroke and Epilepsy
• Country specific Patient pool of Heart attack and stroke, Epilepsy
• Disease progression (Pattern analysis)

Procedure Volume Data

• Number of surgeries for Epilepsy, Heart failure, coutry wise

Surgeons / Physicians Perception analysis

• Fast turn-around analysis of Surgeons response to market events and trends
• Pattern analysis of usage of DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators by Physicians
• Surgeons opinion about products from different companies
• Surgeons qualitative inputs on epidemiology data

 Brand/Product Perception Matrix

• Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
• Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

Pricing Trends

• Cost analysis of Bio-MEMS devices in major countries

Competitive Intelligence

• The company share analysis for the top players of the Bio-MEMS market
• The crucial developments and strategies of companies in the portfolio for Bio-MEMS market

1 Introduction
1.1 Overview
1.2 Objective of study
1.3 Market definition and scope of the study
1.3.1 Market Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key data points from secondary sources
1.5.4 Key data points from primary sources
1.6 Auxillary Factors
1.7 Assumptions
1.8 List of Acronyms

2 Executive Summary
 

3 Market Overview
3.1 Drivers
3.1.1 Technological advancements in BioMEMS devices are driving the market growth
3.1.2 High efficacy and low Cost  
3.1.3 Rising ageing population   
3.2 Restraints
3.2.1  Stringent regulatoryguidelines
3.2.2 High  R&D costs and long product development cycles are hindering the market growth
3.3 Opportunities
3.3.1 Partnerships between engineering and pharmaceutical industries  
3.3.2 Emergence of personalized medicines    
3.4 SUPPORTING DATA   
 

4 BioMEMS Market, By Product
4.1 Introduction
4.2 Implantable BioMEMS
4.2.1 Biosensors
4.2.2 Gyroscopes
4.2.3 Stents
4.2.4 Drug Delivery Devices
4.2.5 Biochips
4.2.6 Accelerometers
4.3 Injectable BioMEMS
4.3.1 Microneedles
4.3.2 Micromodules
4.4 Others
4.4.1 Emerging MEMS devices
4.4.2 Inhalers
4.4.3 Catheters
4.4.4 Micro motors

5 BioMEMS Market, By Application
5.1 Introduction
5.2 Diagnostic
5.3 Therapeutic
5.4 Tissue Engineering
5.5 Others

6 BioMEMS Market, By End Users
6.1 Introduction
6.2 Pharmaceuticals
6.3 Hospitals
6.4 Research Centres
6.5 Food and Agricultural Industry
6.6 Home Diagnostics
6.7 Others

7 Geographic Analysis
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia
7.5 Rest-of-the-World

8 Competitive Landscape
8.1 BioMEMS, by companies
8.2 BioMEMS, by Developments

9 Company Profiles

10.1 Tronics
10.1.1 Overview
10.1.2 Product Portfolio
10.1.3 Financials
10.1.4 Stategy
10.2 Abbott Diagnostics
10.2.1 Overview
10.2.2 Product Portfolio
10.2.3 Financials
10.2.4 Stategy
10.3 Nova Biomedical
10.3.1 Overview
10.3.2 Product Portfolio
10.3.3 Financials
10.3.4 Stategy
10.4 Boehringer Ingelheim
10.4.1 Overview
10.4.2 Product Portfolio
10.4.3 Financials
10.4.4 Stategy
10.5 Innovative Biosensors, Inc.
10.5.1 Overview
10.5.2 Product Portfolio
10.5.3 Financials
10.5.4 Stategy
10.6 ForteBio
10.6.1 Overview
10.6.2 Product Portfolio
10.6.3 Financials
10.6.4 Stategy
10.7 Fraunhofer-IMS
10.7.1 Overview
10.7.2 Product Portfolio
10.7.3 Financials
10.7.4 Stategy
10.8 Affymetrix
10.8.1 Overview
10.8.2 Product Portfolio
10.8.3 Financials
10.8.4 Stategy
10.9 Medtronic
10.9.1 Overview
10.9.2 Product Portfolio
10.9.3 Financials
10.9.4 Stategy
10.10 Johnson&Johnson Ltd.
10.10.1 Overview
10.10.2 Product Portfolio
10.10.3 Financials
10.10.4 Stategy
10.11 Roshe Diagnostics
10.11.1 Overview
10.11.2 Product Portfolio
10.11.3 Financials
10.11.4 Stategy
10.12 Boston Scientific
10.12.1 Overview
10.12.2 Product Portfolio
10.12.3 Financials
10.12.4 Stategy
10.13 Biosensors International Ltd.
10.13.1 Overview
10.13.2 Product Portfolio
10.13.3 Financials
10.13.4 Stategy
10.14 Palmaz scientific
10.14.1 Overview
10.14.2 Product Portfolio
10.14.3 Financials
10.14.4 Stategy
10.15 PerkinElmer
10.15.1 Overview
10.15.2 Product Portfolio
10.15.3 Financials
10.15.4 Stategy

Please fill in the form below to receive a free copy of the Summary of this Report

* First Name :

* Last Name :

* Designation :

* Company :

* Email(Username) :

* Phone :

* Country :

-- Select Country -- India Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia Herzegovina Botswana Brazil British Virgin Island Brunei Darussalam Bulgaria Burkina Faso Burundi Cote d'Ivoire Cambodia Cameroon Canada Cape Verde Cayman Isls Central African Republic Chad Chile China Colombia Comoros Congo Cook Island Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Falkland Islands (Malvinas) Fiji Finl France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenl Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See Honduras Hong Kong Special Administrative Hungary Iceland Indonesia Iran (Islamic Republic of Iran) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Special Administrative Region of China Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Micronesia Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherland Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Islands Northern Mariana Islands Norway Occupied Palestinian Territory Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Republic of Korea Republic of Moldova Romania Russian Federation Rwa Saint Helena Saint Kitts Nevis Saint Lucia Saint Pierre Miquelon Saint Vincent the Grenadines Samoa San Marino Sao Tome Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Svalbard Jan Mayen Islands Swazil Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tokelau Tonga Trinidad Tobago Tunisia Turkey Turkmenistan Turks Caicos Isls Tuvalu Uga Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States United States Virgin Isls Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Wallis Futuna Isls Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Comments :

Reports Interested in :Global Bio-MEMS Market Research Report

* Enter the text from the image to the text box :